CeriBell, Inc. (CBLL) vs Cullinan Therapeutics, Inc. (CGEM)
A side-by-side comparison of CeriBell, Inc. and Cullinan Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CBLL
CeriBell, Inc.
$24.60HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
CGEM
Cullinan Therapeutics, Inc.
$17.21HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
Total return — CBLL vs CGEM
growth of $100 · dividends reinvested · last 2yCBLL -0.6% (-0.3%/yr)CGEM +1.1% (+0.5%/yr)CGEM compounded faster over this window
CBLL CGEM
CBLL vs CGEM: by the numbers
- •CGEM is the larger company ($1.06B vs $933M market cap).
- •Both run net losses; CGEM's is the smaller (0.00% vs -64.73% net margin).
Metrics side by side
Valuation
| Metric | CBLL | CGEM |
|---|---|---|
| P/S ratio | 9.15 | N/A |
| P/B ratio | 7.27 | 3.29 |
Profitability
| Metric | CBLL | CGEM |
|---|---|---|
| Gross margin | 88.90% | 0.00% |
| Operating margin | -68.62% | 0.00% |
| Net margin | -64.73% | 0.00% |
| ROE | -51.43% | -63.62% |
| ROIC | -46.54% | -68.64% |
Growth (annualized)
| Metric | CBLL | CGEM |
|---|---|---|
| Total return CAGR (5Y) | N/A | -7.48% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.